35 related articles for article (PubMed ID: 1493838)
1. Rationale for treatment of silent myocardial ischemia: focus on nifedipine.
Nesto RW
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():929-34. PubMed ID: 2076402
[TBL] [Abstract][Full Text] [Related]
2. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects.
Boddeke E; Hugtenburg J; Jap W; Heynis J; van Zwieten P
Trends Pharmacol Sci; 1989 Oct; 10(10):397-400. PubMed ID: 2694536
[TBL] [Abstract][Full Text] [Related]
3. 24-hour anti-ischaemic action with once daily nifedipine. Experience obtained with a fatty-alcohol matrix tablet in patients with coronary artery disease.
Woodcock BG; Thürmann PA; Pfleiderer S; Reifart N
Eur J Clin Pharmacol; 1992; 43(6):587-90. PubMed ID: 1493838
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibition in chronic stable angina: effects on myocardial ischaemia and comparison with nifedipine.
Ikram H; Low CJ; Shirlaw TM; Foy SG; Crozier IG; Richards AM; Khurmi NS; Horsburgh RJ
Br Heart J; 1994 Jan; 71(1):30-3. PubMed ID: 8297690
[TBL] [Abstract][Full Text] [Related]
5. Isosorbide-5-mononitrate and nifedipine can reduce ischaemic ST-segment changes during Holter monitoring in patients with spontaneous angina pectoris.
von Arnim T; Erath A; Reuschel-Janetschek E
Eur Heart J; 1988 Jan; 9 Suppl A():113-8. PubMed ID: 3409907
[TBL] [Abstract][Full Text] [Related]
6. Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.
el-Tamimi H; Davies GJ
Br Heart J; 1992 Sep; 68(3):291-5. PubMed ID: 1389761
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris.
Wallace WA; Wellington KL; Chess MA; Liang CS
Am J Cardiol; 1994 Jan; 73(1):23-8. PubMed ID: 8279372
[TBL] [Abstract][Full Text] [Related]
8. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
9. [THE CLIMBING STEP, A SIMPLE PROCEDURE FOR EXACTLY MEASURABLE AND REPRODUCIABLE EXERCISE TESTS].
KALTENBACH M; KLEPZIG H; TSCHIRDEWAHN B
Med Klin; 1964 Feb; 59():248-54. PubMed ID: 14135755
[No Abstract] [Full Text] [Related]
10. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
Fox KM; Mulcahy DA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine: kinetics and dynamics in healthy subjects.
Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
[TBL] [Abstract][Full Text] [Related]
12. Treatment of angina pectoris with nifedipine: importance of dose titration.
Deanfield J; Wright C; Fox K
Br Med J (Clin Res Ed); 1983 May; 286(6376):1467-70. PubMed ID: 6405844
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris.
Ardissino D; De Servi S; Salerno JA; Specchia G; Previtali M; Mussini A; Bobba P
Eur Heart J; 1983 Dec; 4(12):873-81. PubMed ID: 6363078
[TBL] [Abstract][Full Text] [Related]
14. Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration.
Chaitman BR; Wagniart P; Pasternac A; Brevers G; Scholl JM; Lam J; Methe M; Ferguson RJ; Bourassa MG
Am J Cardiol; 1984 Jan; 53(1):1-9. PubMed ID: 6362383
[TBL] [Abstract][Full Text] [Related]
15. Lack of diurnal variation in maximal symptom-limited exercise test response in chronic stable angina.
Khurmi NS; Raftery EB
Am J Cardiol; 1988 Jan; 61(1):38-42. PubMed ID: 3337015
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
